Genetic changes of the E‐cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma

References

• Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with fi-catenin. Science 1993; 262: 1743–5.
   Web of Science ®Google Scholar
• Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24: 73–6.
   PubMed Web of Science ®Google Scholar
• Sieber OM, Tomlison IP, Lamlum H. The adenomatous polyposis coli (APC) tumour suppressor—genetics, function and disease. Mol Med Today 2000; 6: 462–9.
   Google Scholar
• Peifer M, Polakis P. Wnt signaling in oncogenesis and embriogenesis—a look outside the nucleus. Science 2000; 287: 1606–9.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159–70.
   PubMed Web of Science ®Google Scholar
• Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589–600.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993; 90: 2846–50.
   PubMed Web of Science ®Google Scholar
• Guilford P. E-cadherin downregulation in cancer: fuel on the fire?Mol Med Today 1999; 5: 172–7.
   PubMedGoogle Scholar
• Berx G, Staes K, van Hengel J, et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995; 26: 281–9.
   PubMed Web of Science ®Google Scholar
• Efstathiou JA, Liu D, Wheeler JMD, et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. PNAS Online 1999; 96: 2316–21.
   PubMed Web of Science ®Google Scholar
• Berx G, Becker KF, Hofler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12: 226–37.
   PubMed Web of Science ®Google Scholar
• Machado JC, Soares P, Carneiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999; 79: 459–65.
   PubMed Web of Science ®Google Scholar
• Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402–5.
   PubMed Web of Science ®Google Scholar
• Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994; 54: 2852–5.
   PubMed Web of Science ®Google Scholar
• Velickovic M, Delahunt B, Stfirkel S, et al. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res 2001; 61: 4815–9.
   PubMed Web of Science ®Google Scholar
• Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor sup-pressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 2001; 98: 7504–9.
   PubMed Web of Science ®Google Scholar
• DalCin P, Li FP, Prout GR Jr, et al. Involvement of chromosomes 3 and 5 in renal cell carcinoma. Cancer Genet Cytogenet 1988; 35: 41–6.
   PubMedGoogle Scholar
• Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg Classification of renal cell tumours. J Pathol 1997; 183: 131–3.
   PubMed Web of Science ®Google Scholar
• Ogawa 0, Habuch T, Kakehi Y, et al. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res 1992; 52: 1881–5.
   Google Scholar
• Störkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma. Cancer 1997; 80: 987–9.
   Google Scholar
• Peéina-Slaus N, Pavelié K, Pavelié J. Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas. J Mol Med 1999; 77: 446–53.
   PubMed Web of Science ®Google Scholar
• Kraus C, Ballhausen WG. Two intragenic polymorphisms of the APC-gene detected by PCR and enzymatic digestion. Hum Genet 1992; 88: 705–6.
   PubMed Web of Science ®Google Scholar
• Gao X, Zacharek A, Grignon D, et al. High frequency of loss of expression and allelic deletion of the APC and MCC genes in human prostate cancer. Int J Oncol 1995; 6: 111–17.
   PubMed Web of Science ®Google Scholar
• Peéina-Slaus N, Gall-Trogelj K, Kapitanovié S, Pavelié J, Pavelié K. Novel alleles of the D16S752 polymorphic genetic marker linked to E-cadherin gene: a potential population marker. Coll Antropol 2002; 26: 85–8.
   Google Scholar
• Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345–7.
   PubMed Web of Science ®Google Scholar
• Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558–61.
   PubMed Web of Science ®Google Scholar
• Huiping C, Sigurgeirsdottir JR, Jonasson JG, et al. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 1999; 81: 1103–10.
   PubMed Web of Science ®Google Scholar
• Tycko B. Epigenetic gene silencing in cancer. J Clin Invest 2000; 105: 401–7.
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Kitazawa R, Maeda S, et al. Methylation of CpG loci in 5-flanking region alters steady-state expression of adenomatous polyposis coli gene in colon cancer cell lines. J Cell Biochem 2001; 80: 415–23.
   PubMed Web of Science ®Google Scholar
• Hulsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction with fi-catenin and the cytoskeleton. J Cell Biol 1994; 127: 2061–9.
   Google Scholar